Accordingly, we measured changes in cellular migration in highly invasive breast cancer cells (MDA-MB-231) which had high ATP production by glycolysis (Fig. 3d), treated with leptin, CQ, or oxidative phosphorylation (OXPHOS) inhibitors that prevent mitochondrial ATP formation (oligomycin and antimycin A). Here, LEP is linked to breast cancer.